Molluscum Contagiosum Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.A Phase 3 Molluscum Contagiosum Efficacy and Safety Study
Condition: Molluscum Contagiosum Interventions: Drug: SB206 10.3% berdazimer; Drug: vehicle gel Sponsors: Novan, Inc.; Therapeutics, Inc.; Synteract, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 2, 2020 Category: Research Source Type: clinical trials
A Phase 3 Molluscum Contagiosum Efficacy and Safety Study
Condition: Molluscum Contagiosum Interventions: Drug: SB206 10.3% berdazimer; Drug: vehicle gel Sponsors: Novan, Inc.; Therapeutics, Inc.; Synteract, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 2, 2020 Category: Research Source Type: clinical trials
A Phase 3 Molluscum Contagiosum Efficacy and Safety Study
Condition: Molluscum Contagiosum Interventions: Drug: SB206 10.3% berdazimer; Drug: vehicle gel Sponsors: Novan, Inc.; Therapeutics, Inc.; Synteract, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 2, 2020 Category: Research Source Type: clinical trials
The Effectiveness of Oral Acyclovir in the Treatment of Molluscum Contagiosum in Children
Condition: Molluscum Contagiosum Interventions: Drug: Acyclovir; Drug: KOH 10 % Sponsors: Dalia Mahran; assistant professor Ghada M. Khafagy; Dr. Marwa Diaaeldeen Abbass Hasan; Prof. Dr. Emad Taha Abd-Elahim Ebiad Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 20, 2020 Category: Research Source Type: clinical trials
